Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 5Polycystic Ovary Syndrome 3Neoplasms 3Prostatic Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Wilms Tumor 1Venous Thromboembolism 1Tuberous Sclerosis 1Thrombosis 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Perioperative Inflammatory Response 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Margins of Excision 1Lymphangioleiomyomatosis 1

Interventions

varlilumab 1Ultrasonography 1Tumor Burden 1Simvastatin 1Observation 1Narrow Band Imaging 1Interferon alpha-2 1Indocyanine Green 1Everolimus 1Endoscopic Mucosal Resection 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Margins of Excision × Simvastatin × Clear all
NCT04418089 2020-06-05

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

Indonesia University

Phase 2 Completed
60 enrolled
Breast

Margins of Excision, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡